iGenomX International Genomics Corp
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
iGenomX International Genomics Corp - overview
Location
Carlsbad, CA, US
Primary Industry
Biotechnology
About
Based in California, US, and founded in 2012, iGenomX International Genomics Corp develops sample preparation technology to provide clinical sequencing for recessive genetic disorders. The company was founded by the CEO Keith Brown. In April 2019, the company raised USD 2. 11 million in Series A funding from unspecified investors.
In June 2021, the company iGenomX International Genomics Corp acquired Twist Bioscience, Inc. iGenomX International Genomics Corp technology specializes in improving DNA sequencing through next-generation sequencing (NGS) library construction for population and disease genetics, agricultural, microbiome, and synthetic biology applications, allowing their clients to obtain data and workflow at a fraction of the cost. The company generates revenue through the sale of the developed therapies to pharmaceutical companies.
Current Investors
Twist Bioscience Corp.
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Website
www.igenomx.com
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.